Side effects of Ozempic and Mounjaro: what to expect and how to manage them

Reading time: 12 minutes. Last updated: April 2026. Reviewed by Dr. David Céspedes, Specialist in Preventive Medicine and Longevity.

Introduction

If you are considering starting treatment with Ozempic, Mounjaro or any other GLP-1 receptor agonist, or if you are already on treatment and are worried about the symptoms you are experiencing, this article is for you. Side effects are a reality of these medicines, and they are also the main cause of treatment discontinuation in the first few weeks.

The good news: most are manageable. The key is knowing what to expect, how to recognise them, when they are normal and when they require urgent medical attention, and above all, how to minimise and manage them with the right clinical strategies. This guide answers all that with medical rigour, reviewed by Dr. David Céspedes, a licensed endocrinologist.

General overview: why side effects appear

GLP-1 receptor agonists act on multiple body systems, which explains both their efficacy and their side-effect profile. Most adverse effects are a direct consequence of their therapeutic mechanisms of action:

• Slowing of gastric emptying: causes a feeling of fullness, reflux, sometimes nausea and vomiting.
• Brain action on appetite centres: can cause fatigue, initial feelings of weakness, occasional mood changes.
• Effects on intestinal transit: diarrhoea or constipation depending on individual response.

According to clinical trials, between 40% and 60% of patients experience some side effect, but only 5 to 10% discontinue treatment for this reason when titration and follow-up are adequate.

Common side effects

Nausea

The most frequent side effect, especially during the progressive titration of doses. It is usually mild to moderate and tends to decrease or disappear after the first 4 to 8 weeks. Approximately 20 to 40% of patients experience it at the start.

Management strategies:

• Eat smaller and more frequent portions.
• Avoid fatty, very spicy or very sweet foods during the first weeks.
• Eat slowly and chew well.
• Avoid lying down immediately after eating.
• Adequate hydration but in small sips, not large amounts at once.
• Ginger, as an infusion or in capsules, can help some patients.
• If it persists, the doctor may slow down the titration or temporarily maintain the dose without increasing it.

Vomiting

Less frequent than nausea, but present in the initial phase. They are usually episodic. Approximately 10 to 20% of patients.

Management strategies:

• All the above applicable to nausea.
• Actively monitor hydration.
• Consult the doctor if they are frequent or prevent adequate intake.

Diarrhoea

A common effect, especially with higher doses. It is usually self-limited and improves over time.

Management strategies:

• Maintain good hydration with solutions containing electrolytes.
• Avoid foods that may aggravate it (dairy, spicy, excessive caffeine, alcohol).
• Consult the doctor if it is severe or persistent.

Constipation

Paradoxically, it can also appear due to the slowing of intestinal transit. Frequency similar to diarrhoea.

Management strategies:

• Increase fibre intake (vegetables, fruit, legumes) whenever tolerated.
• Plenty of hydration.
• Regular physical activity.
• Magnesium supplementation can help (Coeus's Retromag is specifically formulated for this).

Reflux and feeling of fullness

Due to the slowing of gastric emptying. Frequent, usually mild.

Management strategies:

• Small portions.
• Do not lie down for at least 2 hours after eating.
• Avoid foods that worsen reflux individually.
• In persistent cases, the doctor may consider occasional gastric protection.

Initial fatigue

During the first weeks, some patients report fatigue or weakness, related to the metabolic adaptation to treatment and to the caloric deficit that occurs.

Management strategies:

• Ensure sufficient protein intake (1.2 to 1.6 grams per kilo of body weight).
• Maintain hydration.
• Do not drastically reduce the intake of complex carbohydrates.
• Electrolyte supplementation if appropriate.

Pain or discomfort at the injection site

Generally mild and transient. Some patients develop small nodules that disappear within days.

Management strategies:

• Rotate the injection site (abdomen, thigh, arm).
• Bring the medicine to room temperature before injecting (do not inject directly from the fridge).
• Correct injection technique.

Rare but serious side effects

Some side effects are rare but require urgent medical attention if they appear. It is important for any patient on treatment to be aware of them in order to recognise them.

Acute pancreatitis

Incidence: less than 1%. Symptoms: intense and persistent abdominal pain that may radiate to the back, with nausea and vomiting. Any severe abdominal pain in a patient on treatment with GLP-1 agonists must be evaluated urgently.

Gallbladder problems (cholelithiasis, cholecystitis)

Rapid weight loss and GLP-1 agonists slightly increase the risk of gallstones. Symptoms: pain in the right upper quadrant, nausea, vomiting, intolerance to fats. Requires medical evaluation.

Thyroid alterations

Animal studies showed a risk of thyroid tumours (medullary thyroid carcinoma) with these medicines. In humans, the evidence is not conclusive, but as a precaution they are contraindicated in patients with a personal or family history of this tumour or of MEN-2 syndrome.

Hypoglycaemia

Low risk when used as monotherapy (the glucose-dependent mechanism minimises the risk), but it can appear in patients with type 2 diabetes who also take insulin or sulfonylureas. Symptoms: sweating, tremor, confusion, sudden intense hunger.

Allergic reactions

Rare but possible. From skin rashes to serious reactions (angioedema, anaphylaxis). Any extensive skin reaction or respiratory symptoms after injection require urgent consultation.

How side effects are clinically managed

The difference between a patient who tolerates treatment well and one who gives up in the third week usually lies in the quality of the medical follow-up. The standard clinical strategies to minimise side effects include:

Progressive dose titration

All GLP-1 agonists are started at low doses and increased progressively over weeks or months. This titration allows the body to adapt gradually and significantly reduces the incidence of side effects. Skipping titration steps to "go faster" is a frequent clinical error that leads to discontinuation.

Individualised adjustments

If a patient tolerates a dose poorly, the doctor may maintain that dose for several additional weeks before increasing, or temporarily return to a lower dose. The regimen is flexible and must adapt to the individual response.

Specific nutritional interventions

A tailored nutritional plan significantly reduces digestive effects. Smaller portions, quality of food, meal timing, structured hydration.

Complementary supplementation

Magnesium for nocturnal cramps (Retromag), sufficient protein to preserve muscle mass, electrolytes in cases of diarrhoea, occasional digestive support. A serious medical programme includes specific supplementation recommendations.

Accessible support to resolve doubts

Many side effects generate unnecessary anxiety simply because the patient does not know whether they are normal or not. Having a channel to consult quickly (without waiting for the next appointment) is a decisive factor in adherence. Patients with access to continuous support discontinue treatment significantly less than those who do not.

Differences between Ozempic and Mounjaro in side-effect profile

The side-effect profile is similar between both medicines, with some minor differences:

• Mounjaro at high doses may be associated with a slightly higher incidence of gastrointestinal effects than Ozempic at usual doses.
• However, when titration is done properly, the overall clinical difference is modest.
• Individual tolerability is highly variable: some patients tolerate one better than the other for reasons not fully understood.
• Switching from one medicine to another due to intolerance is a valid clinical option under medical supervision.

When to consult the doctor urgently

Not all side effects require immediate consultation, but some symptoms do. You should contact your doctor urgently if the following appear:

• Intense and persistent abdominal pain, especially if it radiates to the back.
• Vomiting that prevents hydration for more than 24 hours.
• Severe diarrhoea with signs of dehydration.
• Severe pain in the gallbladder area, yellow eyes, dark urine.
• Extensive skin reactions or respiratory difficulty.
• Symptoms of severe hypoglycaemia in diabetic patients.
• Sudden visual changes (in patients with diabetic retinopathy).
• Suicidal ideation or behaviour (a very rare but reported effect).

Why real medical follow-up reduces discontinuation

Adherence studies show overwhelming differences between patients with and without continuous medical follow-up:

• Patients with monthly follow-up and accessible support: treatment continuity rates at 12 months above 70%.
• Patients without adequate follow-up: discontinuation rates above 50% in the first 3 months, many due to manageable side effects.

The efficacy of treatment depends on completing the plan. Giving up in the fourth week due to manageable nausea is losing the full benefit of the treatment and returning to the starting point.

What distinguishes a serious medical protocol

The criteria that distinguish an adequate medical programme in terms of side-effect management are:

• Complete and honest explanation of expected side effects before starting.
• Titration plan personalised according to tolerability.
• Real medical availability for consultations between scheduled visits.
• 24/7 support to resolve doubts at the moment they arise.
• Specific supplementation and nutrition recommendations to mitigate effects.
• Flexibility to adjust the regimen according to individual response.
• Clear plan on what to do if serious effects appear.

Conclusion

The side effects of Ozempic and Mounjaro are real, they are frequent especially in the initial phase, and they are the main cause of premature discontinuation of treatment. But they are also, in the vast majority, manageable with known clinical strategies and adequate medical follow-up.

The difference between a successful treatment and a failed treatment is usually not in the medicine chosen, but in the quality of the clinical support. A patient who has access to their doctor to resolve persistent nausea in week 3 has very different chances of completing the treatment than a patient reading forums at 3 in the morning wondering whether what is happening to them is normal.

The clinical recommendation is clear: these treatments should only be carried out under real medical supervision, with continuous follow-up, accessible support and a comprehensive plan. Any service that offers them without these components is compromising both safety and efficacy.

Side effects are manageable, but they require real medical follow-up

At FitRX the follow-up is monthly with your assigned endocrinologist, with 24/7 support through AiON to resolve doubts at the moment. Dr. David Céspedes, a licensed endocrinologist, accompanies each phase of the treatment with personalised adjustments according to your individual response. If you are not a clinical candidate, you pay nothing.

👉 Find out how the protocol works

Frequently asked questions

How long do the side effects of Ozempic and Mounjaro last?

Most side effects (nausea, fatigue, digestive discomfort) are most intense during the titration phase and tend to decrease or disappear after 4 to 8 weeks, as the body adapts.

Can I take antiemetics for nausea?

Only under medical indication. Some antiemetics can be used occasionally, but the main strategy should be to adjust titration and diet. Your doctor will tell you what to do in your case.

Are side effects worse with Mounjaro than with Ozempic?

Slightly more frequent with Mounjaro at high doses, but the overall clinical difference is modest when titration is done correctly. Individual tolerability is very variable.

What happens if I do not tolerate the treatment?

There are options: adjusting the titration regimen, switching to another agonist with a different profile, or considering non-pharmacological strategies. The decision is made with the doctor.

Do side effects disappear when stopping the medicine?

Yes, most gastrointestinal side effects disappear quickly when treatment is suspended. Serious effects are rare and require specific medical evaluation.

Legal notice

This content is informative and educational. It does not replace professional medical advice, diagnosis or treatment under any circumstances. The medicines mentioned in this article are drugs subject to medical prescription whose dispensation requires an official prescription issued by an authorised healthcare professional. Always consult an endocrinologist before starting any treatment for weight loss. If you are being treated with any of these medicines and experience side effects that worry you, contact your prescribing doctor immediately.